Hudock Inc’s Lexicon Pharmaceuticals LXRX Stock Holding History

Hudock Inc’s Portfolio LXRX Stock Details LXRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-429	Closed	-$3K	–	587
2015 Q1	$3K	Sell	429 -571	-57%	-$3.9K	﹤0.01%	526
2014 Q4	$6K	Hold	1,000	–	–	﹤0.01%	428
2014 Q3	$10K	Hold	1,000	–	–	0.01%	394
2014 Q2	$11K	Hold	1,000	–	–	0.01%	388
2014 Q1	$12K	Hold	1,000	–	–	0.01%	358
2013 Q4	$13K	Hold	1,000	–	–	0.01%	356
2013 Q3	$17K	Hold	1,000	–	–	0.02%	288
2013 Q2	$15K	Buy	+1,000	New	+$15.2K	0.02%	310

Other funds holding LXRX

Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

Ulys LLC New York $25.4M AUM 201.03% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

MCM

Masters Capital Management Atlanta, Georgia $3.9B AUM 50.88% 1-Year Est. Return

TRSOTSOK

Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $14.7B AUM 42.39% 1-Year Est. Return

Hudock Inc's LXRX Position: Q2 2015 in Review

Hudock Inc sold out of Lexicon Pharmaceuticals (LXRX) in Q2 2015, closing a stake of 429 shares — an estimated $3K sold.

Hudock Inc first reported a position in LXRX in Q2 2013 and held it in 8 quarters. The position peaked at $17K in Q3 2013. 94 funds tracked by Wall St. Rank hold LXRX as of Q2 2015.

Hudock Inc reported no remaining Lexicon Pharmaceuticals position as of Q2 2015 after selling out during the quarter.
Hudock Inc sold 429 Lexicon Pharmaceuticals shares in Q2 2015, an estimated $3K.
Hudock Inc first reported a position in Lexicon Pharmaceuticals in Q2 2013 and held it in 8 quarters.
Hudock Inc's Lexicon Pharmaceuticals position peaked at $17K in Q3 2013.
94 funds tracked by Wall St. Rank held Lexicon Pharmaceuticals as of Q2 2015.

Based on Hudock Inc's 13F filing for Q2 2015, filed 13 Aug 2015.